How bio-questionable are the different recombinant human erythropoietin copy products in Thailand?
Purpose: The high prevalence of pure red cell aplasia in Thailand has been associated with the sharp increase in number of recombinant human erythropoietin (rhEPO) copy products, based on a classical generic regulatory pathway, which have entered the market. This study aims to assess the quality of...
Saved in:
Main Authors: | Liem Andhyk Halim, Vera Brinks, Wim Jiskoot, Stefan Romeijn, Kearkiat Praditpornsilpa, Anunchai Assawamakin, Huub Schellekens |
---|---|
Other Authors: | Utrecht Institute of Pharmaceutical Sciences |
Format: | Article |
Published: |
2018
|
Subjects: | |
Online Access: | https://repository.li.mahidol.ac.th/handle/123456789/33495 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | Mahidol University |
Similar Items
-
Rechallenge with intravenous recombinant human erythropoietin can be successful following the treatment of anti-recombinant erythropoietin associated pure red cell aplasia
by: Kearkiat Praditpornsilpa, et al.
Published: (2018) -
Biosimilar recombinant human erythropoietin induces the production of neutralizing antibodies
by: Kearkiat Praditpornsilpa, et al.
Published: (2018) -
Biosimilar recombinant human erythropoietin induces the production of neutralizing antibodies
by: Kearkiat Praditpornsilpa, et al.
Published: (2018) -
Biosimilar recombinant human erythropoietin induces the production of neutralizing antibodies
by: Praditpornsilpa K., et al.
Published: (2017) -
Subcutaneous recombinant human erythropoietin in patients on CAPD.
by: Lye, W.C., et al.
Published: (2016)